140 related articles for article (PubMed ID: 23675044)
1. Advanced antigen delivery of murine survivin: chimeric virus-like particles in cancer vaccine research.
Schumacher T; Ruehland C; Schultheiss C; Brinkman M; Roedel F; Reiser CO; Hess J; Reichel C
Int J Biomed Sci; 2007 Sep; 3(3):199-205. PubMed ID: 23675044
[TBL] [Abstract][Full Text] [Related]
2. Therapy with multi-epitope virus-like particles of B19 parvovirus reduce tumor growth and lung metastasis in an aggressive breast cancer mouse model.
Jiménez-Chávez ÁJ; Moreno-Fierros L; Bustos-Jaimes I
Vaccine; 2019 Nov; 37(49):7256-7268. PubMed ID: 31570181
[TBL] [Abstract][Full Text] [Related]
3. Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model.
Chu X; Li Y; Long Q; Xia Y; Yao Y; Sun W; Huang W; Yang X; Liu C; Ma Y
Int J Nanomedicine; 2016; 11():2417-29. PubMed ID: 27313455
[TBL] [Abstract][Full Text] [Related]
4. Chimeric Virus-Like Particles and Capsomeres Induce Similar CD8
Pattinson DJ; Apte SH; Wibowo N; Rivera-Hernandez T; Groves PL; Middelberg APJ; Doolan DL
Front Immunol; 2020; 11():564627. PubMed ID: 33133076
[TBL] [Abstract][Full Text] [Related]
5. A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection.
Zhang X; Zhao B; Ding M; Song S; Kang Y; Yu Y; Xu M; Xiang T; Gao L; Feng Q; Zhao Q; Zeng MS; Krummenacher C; Zeng YX
Theranostics; 2020; 10(13):5704-5718. PubMed ID: 32483413
[No Abstract] [Full Text] [Related]
6. Antigen delivery by virus-like particles for immunotherapeutic vaccination.
Al-Barwani F; Donaldson B; Pelham SJ; Young SL; Ward VK
Ther Deliv; 2014 Nov; 5(11):1223-40. PubMed ID: 25491672
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
8. Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope.
Cheong WS; Reiseger J; Turner SJ; Boyd R; Netter HJ
Antiviral Res; 2009 Feb; 81(2):113-22. PubMed ID: 19007818
[TBL] [Abstract][Full Text] [Related]
9. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
[TBL] [Abstract][Full Text] [Related]
10. Chimeric RHDV Virus-Like Particles Displaying Foot-and-Mouth Disease Virus Epitopes Elicit Neutralizing Antibodies and Confer Partial Protection in Pigs.
Rangel G; Bárcena J; Moreno N; Mata CP; Castón JR; Alejo A; Blanco E
Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34066934
[TBL] [Abstract][Full Text] [Related]
11. Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses.
Campbell K; Young VL; Donaldson BC; Woodall MJ; Shields NJ; Walker GF; Ward VK; Young SL
Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34066318
[TBL] [Abstract][Full Text] [Related]
12. Heterologous prime-boost immunization co-targeting dual antigens inhibit tumor growth and relapse.
Guo Q; Wang L; Xu P; Geng F; Guo J; Dong L; Bao X; Zhou Y; Feng M; Wu J; Wu H; Yu B; Zhang H; Yu X; Kong W
Oncoimmunology; 2020 Nov; 9(1):1841392. PubMed ID: 33224629
[TBL] [Abstract][Full Text] [Related]
13. Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2.
Derouazi M; Wang Y; Marlu R; Epaulard O; Mayol JF; Pasqual N; Le Gouellec A; Polack B; Toussaint B
Bioeng Bugs; 2010; 1(1):51-60. PubMed ID: 21327126
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
15. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
Wei S; Lei Y; Yang J; Wang X; Shu F; Wei X; Lin F; Li B; Cui Y; Zhang H; Wei S
Vaccine; 2018 Apr; 36(17):2273-2281. PubMed ID: 29576303
[TBL] [Abstract][Full Text] [Related]
16. Virus like particles as a platform for cancer vaccine development.
Ong HK; Tan WS; Ho KL
PeerJ; 2017; 5():e4053. PubMed ID: 29158984
[TBL] [Abstract][Full Text] [Related]
17. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
18. Virus-like particles as vaccine.
Chroboczek J; Szurgot I; Szolajska E
Acta Biochim Pol; 2014; 61(3):531-9. PubMed ID: 25273564
[TBL] [Abstract][Full Text] [Related]
19. Chimeric Virus-Like Particles of Prawn Nodavirus Displaying Hepatitis B Virus Immunodominant Region: Biophysical Properties and Cytokine Response.
Ninyio NN; Ho KL; Yong CY; Chee HY; Hamid M; Ong HK; Mariatulqabtiah AR; Tan WS
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672018
[TBL] [Abstract][Full Text] [Related]
20. Chimeric calicivirus-like particles elicit specific immune responses in pigs.
Crisci E; Fraile L; Moreno N; Blanco E; Cabezón R; Costa C; Mussá T; Baratelli M; Martinez-Orellana P; Ganges L; Martínez J; Bárcena J; Montoya M
Vaccine; 2012 Mar; 30(14):2427-39. PubMed ID: 22306796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
